https://doi.org/10.4081/hmr.v2i5.757

Is there a role for immunotherapy in Hodgkin’s disease?

Vol. 2 No. 5: New Drugs in Hematology, Bologna, Italy 5-7 October 2008
Published: June 23, 2009
Abstract Views: 146
PDF: 551
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B Böll
support@pagepress.org
A Engert
To date, most patients with Hodgkin’s lymphoma (HL) can be cured with chemotherapy, radiotherapy or combined modality treatment. However, current treatment is associated with severe side effects and late toxicities such as infertility, cardiovascular damage and secondary malignancies. Moreover, a fraction of patients suffers from refractory disease and cannot be cured with current approaches including high dose chemotherapy and stem cell transplant.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Böll, B., & Engert, A. (2009). Is there a role for immunotherapy in Hodgkin’s disease?. Hematology Meeting Reports (formerly Haematologica Reports), 2(5). https://doi.org/10.4081/hmr.v2i5.757
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).